The November issue of
@TXPDirect
is jam-packed with useful information for our diverse international transplantation readership. We welcome you to visit our Transplantation Direct website for full details in open-access. #OpenAccess#TransplantTwitter https://t.co/fGPNYuGNjd
Can machine perfusion improve outcomes in split liver transplantation (SLT)? Early evidence suggests HOPE may reduce ischemia-reperfusion injury, while NMP offers logistical benefits through extended preservation. #TXPforAll#Transplantation#OpenAccess https://t.co/PEQMNl6fDC
Normothermic ex vivo machine perfusion offers a platform to treat kidneys, livers & hearts before transplantation. This systematic review found molecular benefits in 95% of studies and functional gains in 38%. #TXPforAll#Transplantation#OpenAccess https://t.co/TdwcDUzg68
Kidney transplant with an abnormal urinary tract: possible, but challenging! A review of 511 recipients found comparable 1-year graft survival but more UTIs and urological complications. #TXPforAll#Transplantation#OpenAccess https://t.co/hJQ8cvcXFY
Dion et al. showed that #UTx from brain-dead donors is feasible within a multiorgan procurement setting. #TXPforAll#Transplantation#OpeAccess https://t.co/S54clJSopY
Norovirus in transplant recipients: what actually works is discussed in this scoping review paper by Maung Myint et al. #TXPforAll#Transplantation#norovirus#OpenAccess https://t.co/wLWZsPKvFM
Boyne et al. compared intra-abdominal (IA-NRP) and descending thoracic (DT-NRP) approaches to abdominal normothermic regional perfusion for organ donation after death. #TXPforAll#Transplantation https://t.co/PvXhg7xq2y
DCDD kidneys: higher early rejection, but equivalent graft survival, similar long-term eGFR, and better patient survival vs DNDD in 10,144 ANZDATA recipients. Strong support for using more DCDD kidneys.#TXPforAll#KidneyTransplantation#OpenAccess https://t.co/kqFIFzS0id
Age is not the end of the road for DCD organs! This study shows that septuagenarian DCD grafts can achieve favorable graft survival after both kidney and liver transplantation expanding the donor pool and challenging age-related assumptions. https://t.co/QGpSqS2DI6
Kidney transplantation in older adults: Longer dialysis exposure and donor hypertension increased early complications, while preemptive KT and living donation were protective. #TXPforAll#Transplantation#OpenAccess https://t.co/vWKyEiIU27
This study by Nevermann et al. reports on the lives of people who underwent liver transplantation over 30 years ago. #TXPforAll#Transplantation https://t.co/iEdO3QHl1y
A global survey of 438 critical care & transplant specialists revealed significant knowledge and confidence discrepancies regarding organ acceptance, including infectious risks, cancer history, alcohol consumption, and donation following circulatory death. https://t.co/BIWemqyPHQ
🧬Could HLA-DQ biology hold clues to kidney transplant outcomes? New findings highlight associations between HLA-DQ heterodimers and graft survival, opening new avenues to better understand HLA biology in #transplantation. #TXPforAll#OpenAccess https://t.co/fbfmf8ZZuL
The October issue of
@TXPDirect
is jam-packed with useful information for our diverse international transplantation readership. We welcome you to visit our Transplantation Direct website for full details in open-access. #OpenAccess#TransplantTwitter https://t.co/fGPNYuGNjd
🫘A new synthetic solution for kidney preservation? Omnisol maintained more stable perfusion, near-constant pH and better tissue morphology than Belzer MPS during 24 h HOPE in porcine kidneys. #TXPforAll#Transplantation#OpenAccess https://t.co/LMaIhuVXJt
Can the graft’s DNA tell us how it will perform? This study shows that cell-free DNA—particularly mitochondrial cfDNA—measured during machine perfusion is associated with post-transplant graft outcomes. #TXPforAll#Transplantation https://t.co/NaNONpt1he
This study shows that RSV vaccination induces robust functional humoral immunity in immunocompromised patient groups, with kidney transplant recipients showing the lowest levels. #TXPforAll#Transplantation#Vaccination https://t.co/BEYOviCCUC
Immune Checkpoint Inhibitor therapy showed a trend toward longer overall survival vs standard chemotherapy, with low rates of rejection and allograft loss. #TXPforAll#Transplantation#OpenAccess https://t.co/nTM0K4HOOF
This study shows that weight ratio offers a simple real-time tool to flag size-mismatched grafts and identify recipients who may need closer perioperative monitoring. #TXPforAll#Transplantation#OpenAccess https://t.co/Y8hJ9InCoZ